For security purposes
FOR SECURITY PURPOSES - because Internet Explorer is no longer supported by Microsoft, we suggest that you interact with our secure site through one of our supported browsers - Google Chrome, Firefox, or MS Edge. If you continue to use this website with Internet Explorer you do so at your own risk and you may encounter problems.
Applications
Anticonvulsants on Synergi Max-RP
14223
Separation Mode: Reversed Phase
Reversed Phase
Max-RP
HPLC
Adjuvants, Anesthesia
Pharmaceutical
Therapeutic / Clinical

Applications

Anticonvulsants on Synergi Max-RP
Analytes
1Primidone
2Phenobarbital
3Butalbital
4Pentobarbital
5Amobarbital
6Secobarbital
Compound Name
Primidone
CID
4909
Molecular Formula
C12H14N2O2
Molecular Weight
218
No. Hydrogen Bond Acceptors
2
No. Hydrogen Bond Donors
2
Details
LC Conditions (App ID: 14223)
Column:
Brand Name:
Part No:
Phase Name:
Max-RP
Elution Type:
Isocratic
Mobile Phase:
A: 20mM Potassium phosphate, pH 6.9
B: Acetonitrile
Gradient Profile:
Step No.Time(min)%A%B
107030
Flow Rate:
2 mL/min
Temperature:
22°C
Detection:
UV-Vis Abs.-Variable Wave.(UV) @ 214 nm (22°C)
Sample Note:
SecurityGuard™ Guard Cartridge System extends column lifetime. - SecurityGuard Cartridges, C12 4 x 3.0mm, 10/Pk Part No.: AJ0-6074 - Holder Part No.: KJ0-4282

Order Items Used in This Application

Similar Applications
search
No Data